Literature DB >> 22948661

PTPN14 is required for the density-dependent control of YAP1.

Wenqi Wang1, Jun Huang, Xin Wang, Jingsong Yuan, Xu Li, Lin Feng, Jae-Il Park, Junjie Chen.   

Abstract

Through an shRNA-mediated loss-of-function screen, we identified PTPN14 as a potential tumor suppressor. PTPN14 interacts with yes-associated protein 1 (YAP1), a member of the hippo signaling pathway. We showed that PTPN14 promotes the nucleus-to-cytoplasm translocation of YAP1 during contact inhibition and thus inhibits YAP1 transactivation activity. Interestingly, PTPN14 protein stability was positively controlled by cell density. We identified the CRL2(LRR1) (cullin2 RING ubiquitin ligase complex/leucine-rich repeat protein 1) complex as the E3 ligase that targets PTPN14 for degradation at low cell density. Collectively, these data suggest that PTPN14 acts to suppress cell proliferation by promoting cell density-dependent cytoplasmic translocation of YAP1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948661      PMCID: PMC3435498          DOI: 10.1101/gad.192955.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  69 in total

1.  CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Authors:  Natalia G Starostina; Jennifer M Simpliciano; Michael A McGuirk; Edward T Kipreos
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

Review 2.  Regulation of cell adhesion by protein-tyrosine phosphatases: II. Cell-cell adhesion.

Authors:  Jennifer L Sallee; Erika S Wittchen; Keith Burridge
Journal:  J Biol Chem       Date:  2006-02-23       Impact factor: 5.157

3.  Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma.

Authors:  Lei Zhang; Dong-Xia Ye; Hong-Ya Pan; Kui-Jie Wei; Li-Zhen Wang; Xu-Dong Wang; Guo-Fang Shen; Zhi-Yuan Zhang
Journal:  Oral Oncol       Date:  2011-06-25       Impact factor: 5.337

4.  Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.

Authors:  Carsten Denkert; Wolfgang D Schmitt; Stefan Berger; Angela Reles; Sören Pest; Antje Siegert; Werner Lichtenegger; Manfred Dietel; Steffen Hauptmann
Journal:  Int J Cancer       Date:  2002-12-10       Impact factor: 7.396

5.  Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

Authors:  Tingting Sun; Nicola Aceto; Kristen L Meerbrey; Jessica D Kessler; Chunshui Zhou; Ilenia Migliaccio; Don X Nguyen; Natalya N Pavlova; Maria Botero; Jian Huang; Ronald J Bernardi; Earlene Schmitt; Guang Hu; Mamie Z Li; Noah Dephoure; Steven P Gygi; Mitchell Rao; Chad J Creighton; Susan G Hilsenbeck; Chad A Shaw; Donna Muzny; Richard A Gibbs; David A Wheeler; C Kent Osborne; Rachel Schiff; Mohamed Bentires-Alj; Stephen J Elledge; Thomas F Westbrook
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

7.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

8.  Centrosome separation driven by actin-microfilaments during mitosis is mediated by centrosome-associated tyrosine-phosphorylated cortactin.

Authors:  Wenqi Wang; Luyun Chen; Yubo Ding; Jing Jin; Kan Liao
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

Review 9.  The organizing principle: microenvironmental influences in the normal and malignant breast.

Authors:  Mina J Bissell; Derek C Radisky; Aylin Rizki; Valerie M Weaver; Ole W Petersen
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

10.  YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.

Authors:  J-M Huang; I Nagatomo; E Suzuki; T Mizuno; T Kumagai; A Berezov; H Zhang; B Karlan; M I Greene; Q Wang
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

View more
  88 in total

1.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.

Authors:  Xu Li; Kim My Tran; Kathryn E Aziz; Alexey V Sorokin; Junjie Chen; Wenqi Wang
Journal:  Mol Cell Proteomics       Date:  2016-07-18       Impact factor: 5.911

Review 3.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

Review 4.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

5.  Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.

Authors:  Panfeng Fu; Ramaswamy Ramchandran; Mark Shaaya; Longshuang Huang; David L Ebenezer; Ying Jiang; Yulia Komarova; Stephen M Vogel; Asrar B Malik; Richard D Minshall; Guangwei Du; Nicholas K Tonks; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2020-04-23       Impact factor: 5.157

6.  PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes.

Authors:  Angel Bottini; Dennis J Wu; Rizi Ai; Michelle Le Roux; Beatrix Bartok; Michele Bombardieri; Karen M Doody; Vida Zhang; Cristiano Sacchetti; Martina Zoccheddu; Ana Lonic; Xiaochun Li; David L Boyle; Deepa Hammaker; Tzu-Ching Meng; Lin Liu; Maripat Corr; Stephanie M Stanford; Myles Lewis; Wei Wang; Gary S Firestein; Yeesim Khew-Goodall; Costantino Pitzalis; Nunzio Bottini
Journal:  Ann Rheum Dis       Date:  2019-02-26       Impact factor: 19.103

7.  Defining the protein-protein interaction network of the human hippo pathway.

Authors:  Wenqi Wang; Xu Li; Jun Huang; Lin Feng; Keithlee G Dolinta; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

Review 8.  Mining the function of protein tyrosine phosphatases in health and disease.

Authors:  Hojin Lee; Jae-Sung Yi; Ahmed Lawan; Kisuk Min; Anton M Bennett
Journal:  Semin Cell Dev Biol       Date:  2014-09-26       Impact factor: 7.727

9.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

10.  Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.

Authors:  Shuangbing Xu; Xu Li; Zihua Gong; Wenqi Wang; Yujing Li; Binoj Chandrasekharan Nair; Hailong Piao; Kunyu Yang; Gang Wu; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.